Building a tuberculosis-free world while responding to the COVID-19 pandemic

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-11-03

Type Journal Article Author Michael J. A. Reid Author Sachin Silva Author Nimalan Arinaminpathy Author Eric Goosby URL https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32138-3/abstract Series Comment Volume 396 Issue 10259 Pages 1312-1313 Publication The Lancet ISSN 0140-6736, 1474-547X Date 24/10/2020 Extra Publisher: Elsevier Journal Abbr The Lancet DOI 10.1016/S0140-6736(20)32138-3 Library Catalog www.thelancet.com Language English Abstract In March, 2019, the Lancet Commission on Tuberculosis1 highlighted the opportunity to build a tuberculosis-free world. After years of neglect of this disease, the UN High-Level Meeting on Tuberculosis in September, 2018, made ending tuberculosis a global priority; global leaders committed to important steps, including ambitious country-specific tuberculosis case-finding and prevention targets, and a revitalised research agenda.2 The Lancet Commission concluded that the prospect of a tuberculosis-free world was a realistic objective that could be achieved with sufficient accountability and resources, and detailed the catastrophic consequences of failing to build on that momentum.